Landmark Partnership: Aansh Hospital Brings CDSCO-Approved AI Fertility Tech to Vidarbha with Garbha.ai

Nagpur (Maharashtra) [India], December 24: A significant milestone has been achieved in Central Indian healthcare as Aansh Hospital & IVF Center formally announces its collaboration with Garbha.ai. This partnership establishes Aansh Hospital—recognized as one of the best IVF centers in Vidarbha—as the first facility in Maharashtra and the Central region to deploy this high-precision, government-approved Artificial Intelligence for fertility treatments. The significance of this launch cannot be overstated. For decades, patients in the Vidarbha region faced a difficult choice: settle for standard local care or endure the financial and logistical strain of traveling to metropolitan hubs like Mumbai or Hyderabad for advanced treatment. By joining the ranks of premier institutes in Delhi, Chennai, and Hyderabad, Aansh Hospital has successfully bridged this gap. Led by Dr. Shweta Agarwal, distinguished as the best IVF specialist in the Nagpur and Chandrapur region, the center is now the exclusive provider of the Garbha.ai 5-Product Suite across Vidarbha, Madhya Pradesh, and Chhattisgarh. "Geography should never limit a patient's access to world-class medical science," states Dr. Shweta Agarwal, Medical Director of Aansh IVF Chandrapur. "Our partnership with Garbha.ai ensures that families in Vidarbha no longer need to travel to Mumbai for advanced care. We are delivering metro-grade technology right here in Chandrapur, democratizing access to the highest success rates possible." The AANSH x Garbha.ai Ecosystem: Solving 5 Critical Challenges For families in Chandrapur, Gadchiroli, Wardha, Chimur, and Yavatmal, this integration represents a massive leap forward. Unlike clinics that use AI for just a single step, Aansh has adopted a "Full-Stack" approach that optimizes the entire biological journey. 1. Sperm Selection (Male Factor): In cases of severe male infertility or Oligospermia, finding a viable sperm for ICSI is challenging. Manual selection is subjective. • The AANSH x Garbha.ai Solution: Garbha.ai’s sperm module analyzes motility and morphology in real-time, identifying the absolute best candidate for injection, drastically improving fertilization rates. 2. Oocyte Assessment (Egg Quality): For women with Low AMH or Advanced Maternal Age, egg quality is the primary barrier to success. Traditional microscopy often misses subtle defects. • The AANSH x Garbha.ai Solution: The AI evaluates oocyte vitality before fertilization. This allows the clinical team to optimize protocols instantly, preventing the wastage of precious gametes. 3. EmbryoScore (The Grading Solution): Manual grading of embryos is prone to human error and fatigue. Two different embryologists might grade the same embryo differently. • The AANSH x Garbha.ai Solution: Using India's first CDSCO-approved grading tool, Aansh offers 100% objective analysis. The AI scans thousands of pixel-level details invisible to the human eye to predict implantation potential with mathematical certainty. 4. ERA (The Timing Solution): Implantation failure often occurs because the embryo is transferred when the uterus isn't ready. • The AANSH x Garbha.ai Solution: The Endometrial Receptivity Analysis (ERA) uses genetic mapping to identify the patient's unique "window of implantation," ensuring the transfer happens at the precise biological moment the uterus is receptive. 5. PGx (The Medication Solution): Standard drug protocols can cause side effects or poor response in some women. • The AANSH x Garbha.ai Solution: Pharmacogenomics (PGx) testing analyzes the patient's DNA to determine how they metabolize drugs. This allows Dr. Agarwal to prescribe the exact dosage needed for optimal egg production, avoiding "trial and error." AANSH X Garbha.ai: Performance & Leadership The adoption of this technology at Aansh IVF Chandrapur offers tangible, data-backed benefits over conventional methods found elsewhere in the region: • 94% Accuracy: Reducing human error in embryo grading to near zero. • 25% Higher Success: Increasing implantation rates in the first cycle, which is critical for older patients. • 50% Cost Savings: Achieving pregnancy in fewer cycles reduces the overall financial burden of repeated treatments. • Objective Analysis: Removing subjectivity ensures every patient gets fair, standardized, world-class assessment. Aayush Agarwal, Embryologist & Chief of Hospital Administration, highlights the operational advantage: "By augmenting our clinical expertise with objective, data-driven analysis, we have standardized our outcomes to meet global benchmarks. We analyze invisible parameters that the human eye might miss, maximizing the probability of a healthy pregnancy. This is not just technology; it is a new standard of care." Why Aansh Stands Out in Central India While AI is a global trend, the Aansh-Garbha alliance offers specific advantages for Indian patients that foreign technologies can